Nottingham Clinical Trials Unit
The University of Nottingham
University of Nottingham

 POINT logo_Purple_Final

Study name: POINT                           Status: Ongoing data collection

A multi-centre randomised trial of surgery versus non-surgical splint treatment for proximal phalanx shaft finger fractures in adults


Lead Investigator:

Dr Alexia Karantana

What is the study about?

The POINT trial is looking at whether surgery or splints (supports) are best to treat Proximal Phalanx Shaft (PPS) finger fractures. Though both treatments are used in standard practice and generally give good results, we do not know which treatment is the best for patients. The aim of this study is to improve the care for people with a finger fracture like you, by finding out which treatment provides quicker or more convenient recovery, has fewer complications, and ensures better long-term use of the hand.

Who can take part in the study?

Adults (16+) with a proximal phalanx shaft finger fracture, who can adhere to trial procedures and are willing and able to give fully informed consent.

What is being tested in the study?


Any mode of surgical intervention used in routine care, involving the use of surgical fixation as considered appropriate by the treating specialist. Surgery will be performed in an operating theatre, using an anaesthetic technique appropriate for the patient.

Non-Surgical Splint Treatment:

Any mode of technique and material used in routine care, which may involve the manipulation of the fracture with or without analgesia or local anaesthetic, and subsequent bracing through an externally applied support, usually performed in a clinic or therapy room environment.

What is this being compared to?

See above – both offered as standard treatment on the NHS. 

What are we trying to find out?

To determine the clinical and cost-effectiveness of surgery compared to non-surgical splint treatment for Proximal Phalanx Shaft (PPS) finger fractures in adults.

How many patients do we need?




Useful Links:  




Nottingham Clinical Trials Unit

General enquiries
Telephone: +44 (0)115 8231600